[Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].
作者信息
Robak T
出版信息
Pol Tyg Lek. 1988 Nov 21;43(47):1491-5.
PMID:3266975
Abstract
摘要
相似文献
1
[Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].[白细胞介素2激活的淋巴细胞（LAK细胞）在肿瘤过继性免疫治疗中的应用]
Pol Tyg Lek. 1988 Nov 21;43(47):1491-5.
2
Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.用白细胞介素-2激活的淋巴细胞对恶性疾病进行过继性免疫治疗。
Biken J. 1987 Jun;30(2):29-38.
3
[LAK cells and cancer].[淋巴因子激活的杀伤细胞与癌症]
Gan To Kagaku Ryoho. 1986 Dec;13(12):3327-33.
4
5
[Adoptive immunotherapy of cancer patients with lymphokine-activated killer cells].[应用淋巴因子激活的杀伤细胞对癌症患者进行过继性免疫治疗]
Gan To Kagaku Ryoho. 1987 Mar;14(3 Pt 2):914-21.
6
[Using LAK cells in the adoptive immunotherapy in cancers].[在癌症的过继性免疫治疗中使用淋巴因子激活的杀伤细胞]
Rinsho Ketsueki. 1987 Oct;28(10):1897-8.
7
Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.通过全身性给予淋巴细胞加白细胞介素-2进行癌症免疫治疗。
J Biol Response Mod. 1984 Oct;3(5):501-11.
8
[Lymphokine-activated killer (LAK) adoptive immunotherapy: optimal method for large-scale LAK induction].[淋巴因子激活的杀伤细胞（LAK）过继性免疫疗法：大规模诱导LAK的最佳方法]
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 1):1871-6.
9
[Interleukin 2].[白细胞介素2]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1203-7.
10
Zotero 插件